BRAF and MEK inhibition in melanoma
LA Dossett, RR Kudchadkar… - Expert opinion on drug …, 2015 - Taylor & Francis
Introduction: Selective inhibition of the MAPK pathway with either BRAF or MEK inhibition
has emerged as a key component for the treatment of BRAF-mutant metastatic melanoma …
has emerged as a key component for the treatment of BRAF-mutant metastatic melanoma …
BRAF and MEK inhibition in melanoma.
LA Dossett, RR Kudchadkar, JS Zager - Expert Opinion on Drug …, 2015 - europepmc.org
Selective inhibition of the MAPK pathway with either BRAF or MEK inhibition has emerged
as a key component for the treatment of BRAF-mutant metastatic melanoma. New evidence …
as a key component for the treatment of BRAF-mutant metastatic melanoma. New evidence …
BRAF and MEK inhibition in melanoma
LA Dossett, RR Kudchadkar… - Expert opinion on drug …, 2015 - pubmed.ncbi.nlm.nih.gov
Introduction Selective inhibition of the MAPK pathway with either BRAF or MEK inhibition
has emerged as a key component for the treatment of BRAF-mutant metastatic melanoma …
has emerged as a key component for the treatment of BRAF-mutant metastatic melanoma …